SCHEMBL2783337

SCHEMBL2783337

CCN(CC)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1CC1.O=C(/C=C/CN1CCOCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1CC1

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.70
ERBB2 P04626 15/20 0.70
ERBB4 Q15303 5/20 0.70
GAK O14976 1/20 0.67
RIPK2 O43353 1/20 0.67
NR1I2 O75469 1/20 0.67
LCK P06239 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
CHRM1 P11229 1/20 0.67
SRC P12931 1/20 0.67
DRD2 P14416 1/20 0.67
ADRA2C P18825 1/20 0.67
SLC6A2 P23975 1/20 0.67
MC3R P41968 1/20 0.67
JAK3 P52333 1/20 0.67
SLC6A3 Q01959 1/20 0.67
PDE4D Q08499 1/20 0.67
KCNH2 Q12809 1/20 0.67
RIPK3 Q9Y572 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1919941 1.00 EGFR (0.70) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL29623479 0.94 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL185348 0.94 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL230985 0.94 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL1191587 0.92 EGFR (0.77) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL185032 0.92 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL231418 0.92 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL29623448 0.92 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL14427865 0.91 EGFR (0.78) EGFRERBB2ERBB4GAKRIPK2
SCHEMBL3578549 0.91 EGFR (0.74) EGFRERBB2ERBB4GAKRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393492-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS Boehringer Ingelheim International GmbH (DE) 2011-12-14 EP disclosed
WO-2010089391-A1 NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-08-12 WO disclosed